Educational content on VJHemOnc is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Session III: CAR-T in CLL

Presentations
Update CLL CAR-T trial landscape/JCAR
Tanya Siddiqi
29 October, 2020
The role of CLL tumor cells in resistance to anti-CAR-T cell therapy
Joseph Melenhorst
29 October, 2020
Long-term outcomes of anti-CD19 CAR-T in R/R CLL
David Porter
29 October, 2020